ASDR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Temporal trends of tuberculosis ASIR by Xue Li (285380)

Subjects:

The incidence, death and DALYs in individuals aged 0 to 19 years in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each type of tuberculosis age-standardized incidence rate in 21 regions in 1990 and 2021. by Xue Li (285380)

Subjects:

Each types of tuberculosis ASMR in 1990 and 2021. by Xue Li (285380)

Subjects:

DALYs, ASDR, and Relative change of Tuberculosis in children and Adolescence in global and 21 regions, with EAPC from 1990 and 2021. by Xue Li (285380)

Subjects:

Age standardized incidence rates of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Death number, ASMR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

ASMR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Each types of tuberculosis ASDR in 1990 and 2021. by Xue Li (285380)

Subjects:

Each types of tuberculosis ASIR in 1990 and 2021. by Xue Li (285380)

Subjects:

Death, ASMR, and Relative change of Tuberculosis in children and Adolescence in global and 21 regions, with EAPC from 1990 and 2021. by Xue Li (285380)

Subjects:

Incidence, death and DALYs of TB, by age and sex in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each types of tuberculosis ASDR in 1990 and 2021. by Xue Li (285380)

Subjects:

Incidence number, ASIR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Composition ratio of each types of tuberculosis ASMR in 1990 and 2021. by Xue Li (285380)

Subjects:

DALYs number, ASDR under the age of 20 in 204 countries and territories in 2021. by Xue Li (285380)

Subjects:

Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer by Yubo Wang (556762)

“…Small-cell lung cancer (SCLC) represents a significant public health challenge due to its increasing incidence and high mortality. …”

Enhancing Gene Delivery to Breast Cancer with Highly Efficient siRNA Loading and pH-Responsive Small Extracellular Vesicles by Gaeun Kim (4532863)

“…Small extracellular vesicles (sEVs) are promising nanocarriers for drug delivery to treat a wide range of diseases due to their natural origin and innate homing properties. …”

Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer by Yubo Wang (556762)

“…Small-cell lung cancer (SCLC) represents a significant public health challenge due to its increasing incidence and high mortality. …”